When it comes to AD and risk factors, you need to understand the difference between correlation and causation. For example, diabetes is one of the risk factors for developing AD is diabetes. This does not mean that diabetes causes AD, and not all people with diabetes develop AD. That in mind, the risk factors associated with AD include:
More than 40 percent of people age 85 and older may have AD. Symptoms of AD usually begin after age 60. However, AD is not a normal part of aging. It is a disease.
A parent with AD is one of the main risk factors for developing AD.
Women are slightly more likely to get Alzheimer's disease than men.
Recent studies suggest diabetes may be associated with an increased risk of AD.
High Levels of Homocysteine
A building block of protein, called homocysteine (an amino acid), circulates in the blood. Studies suggest high homocysteine levels are a risk factor AD, vascular dementia, cognitive impairment, and stroke.
Psychological and Experiential Factors
Mounting research indicates psychological and experiential factors may increase one’s risk of AD; for example, social isolation and not regularly participating in brain-stimulating activities.
Mild Cognitive Impairment (MCI)
About 40 percent of people with MCI develop AD within three years—which means people with MCI may or may not progress to AD. MCI is still being explored by scientists, but they know this much:
- It’s a clinical condition in which people experience memory loss greater than expected for their age.
- The memory loss is enough to be noticed and measured.
- The deficit is not enough to compromise a person’s independence. In other words, they can take care of themselves and conduct their normal activities.
MCI memory problems may include:
- losing things often
- forgetting to go to events and appointments
- having more trouble coming up with words than other people of the same age
Poor Diet, Lack of Exercise, and Smoking
A healthy diet, regular exercise, and not smoking all impact your physical and emotional health. These lifestyle choices are believed to play an ancillary role in the development of AD. Additionally, several recent studies suggest that smoking may significantly increase the risk of mental decline and dementia.
Studies show that people with Down syndrome are more likely to develop the hallmarks of Alzheimer’s disease (i.e., amyloid plaques and neurofibrillary tangles).
- Albert, M. S., Dekosky, S. T.,
Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., et al. (2011). The
diagnosis of mild cognitive impairment due to Alzheimer's disease:
Recommendations from the National Institute on Aging and Alzheimer's
Association workgroup. Alzheimers Dement.
- Alzheimer's Association. (2011). Press Release: New Criteria
and Guidelines for the Diagnosis of Alzheimer's Disease Published for the first
Time in 27 Years. The Alzheimer's
- Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A.,
& Bennett, D. A. (2004). Diabetes mellitus and risk of Alzheimer disease
and decline in cognitive function. Arch
Neurol, 61(5), 661-666.
- Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland,
D., & Jones, E. (2011). Alzheimer's disease. Lancet, 377(9770), 1019-1031.
- Bird, T. D. (2010). Early-Onset Familial Alzheimer Disease. University of Washington, Gene Review.
- Birks, J., & Grimley Evans, J. (2009). Ginkgo biloba for
cognitive impairment and dementia. Cochrane
Database Syst Rev(1), CD003120.
- Bosco, D., Fava, A., Plastino, M., Montalcini, T., &
Pujia, A. (2011). Possible implications of Insulin Resistance and Glucose
metabolism in Alzheimer's disease pathogenesis. J Cell Mol Med.
- Boyle, P. A., Buchman, A. S., Barnes, L. L., & Bennett,
D. A. (2010). Effect of a purpose in life on risk of incident Alzheimer disease
and mild cognitive impairment in community-dwelling older persons. Arch Gen Psychiatry, 67(3), 304-310.
- Boyle, P. A., Buchman, A. S., Barnes, L. L., James, B. D.,
& Bennett, D. A. (2010). Association between life space and risk of
mortality in advanced age. J Am Geriatr
Soc, 58(10), 1925-1930.
- Brinkley, T. E., Lovato, J. F., Arnold, A. M., Furberg, C.
D., Kuller, L. H., Burke, G. L., et al. (2010). Effect of Ginkgo biloba on
blood pressure and incidence of hypertension in elderly men and women. Am J Hypertens, 23(5), 528-533.
- Daviglus, M. L., Bell, C. C., Berrettini, W., Bowen, P. E.,
Connolly, E. S., Cox, N. J., et al. (2010). NIH State-of-the-Science Conference
Statement: Preventing Alzheimer's Disease and Cognitive Decline. NIH Consens State Sci Statements, 27(4).
- De Felice, F. G., Vieira, M. N., Bomfim, T. R., Decker, H.,
Velasco, P. T., Lambert, M. P., et al. (2009). Protection of synapses against
Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of
Abeta oligomers. Proc Natl Acad Sci U S
A, 106(6), 1971-1976.
- deIpolyi, A. R., Rankin, K. P., Mucke, L., Miller, B. L.,
& Gorno-Tempini, M. L. (2007). Spatial cognition and the human navigation
network in AD and MCI. Neurology, 69(10),
- DeKosky, S. T., Williamson, J. D., Fitzpatrick, A. L.,
Kronmal, R. A., Ives, D. G., Saxton, J. A., et al. (2008). Ginkgo biloba for
prevention of dementia: a randomized controlled trial. JAMA, 300(19), 2253-2262.
- Fillit, H. M., Butler, R. N., O'Connell, A. W., Albert, M.
S., Birren, J. E., Cotman, C. W., et al. (2002). Achieving and maintaining
cognitive vitality with aging. Mayo Clin
Proc, 77(7), 681-696.
- Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish,
A., Hamshere, M. L., et al. (2009). Genome-wide association study identifies
variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet, 41(10), 1088-1093.
- Herrmann, W., & Obeid, R. (2011). Homocysteine: a
biomarker in neurodegenerative diseases. Clin
Chem Lab Med, 49(3), 435-441.
- Keating, D. J., Chen, C., & Pritchard, M. A. (2006).
Alzheimer's disease and endocytic dysfunction: clues from the Down
syndrome-related proteins, DSCR1 and ITSN1. Ageing
Res Rev, 5(4), 388-401.
- Ladika, D. J., & Gurevitz, S. L. (2011). Identifying the
most common causes of reversible dementias: a review. JAAPA, 24(3), 28-31, 57.
- Li, K., Dai, D., Zhao, B., Yao, L., Yao, S., Wang, B., et al.
(2010). Association between the RAGE G82S polymorphism and Alzheimer's disease.
J Neural Transm, 117(1), 97-104.
- McKhanna, G. M., Knopmanc, D. S., Chertkowd, H., Hyman, B.
T., Clifford R. Jack, J., Kawash, C. H., et al. (2011). The diagnosis of
dementia due to Alzheimer’s disease: Recommendations from the National
Institute on Aging and the Alzheimer’s Association workgroup. Alzheimer’s & Dementia, 1–7.
- Nation, D. A., Hong, S., Jak, A. J., Delano-Wood, L., Mills,
P. J., Bondi, M. W., et al. (2011). Stress, exercise, and Alzheimer's disease:
A neurovascular pathway. Med Hypotheses.
- National Library of Medicine. (2011). Alzheimer's Disease. Medline Plus; U.S. National Library of
Medicine; National Institutes of Health.
- NCCAM. (2011). National Center for Complementary and
Alternative Medicine: The Ginkgo Evaluation of Memory (GEM) Study. National Institutes of Health' National
Center for Complementary and Alternative Medicine.
- NIA. (2008). Alzheimer's Disease: Unraveling the Mystery. National Institute on Aging; National Institutes of Heath; US
Department of Health and Human Services; NIH Publication Number 08-3782, 1-43.
- NIA. (2011). Caring for a Person with Alzheimer's Disease;
Medicine Chart. National Institutes of
Health; National Institute on Aging; Alzheimer's Disease Education &
- NINDS. (2010). NINDS Alzheimer's Disease Information Page. National Institute of Neurological Disorders
and Stroke; National Institutes of Health; US Department of Health & Human
- NINDS. (2011). Dementia: Hope Through Research. National Institute of Neurological Disorders
and Stroke of the National Institutes of Health.
- Panza, F., Frisardi, V., Imbimbo, B. P., D'Onofrio, G.,
Pietrarossa, G., Seripa, D., et al. (2010). Bapineuzumab: anti-beta-amyloid
monoclonal antibodies for the treatment of Alzheimer's disease. Immunotherapy, 2(6), 767-782.
- Redish, A. D. (2001). The hippocampal debate: are we asking
the right questions? Behav Brain Res, 127(1-2),
- Reitz, C., Brayne, C., & Mayeux, R. (2011). Epidemiology
of Alzheimer disease. Nat Rev Neurol, 7(3),
- Reitz, C., den Heijer, T., van Duijn, C., Hofman, A., &
Breteler, M. M. (2007). Relation between smoking and risk of dementia and
Alzheimer disease: the Rotterdam Study. Neurology,
- Seneff, S., Wainwright, G., & Mascitelli, L. (2011).
Nutrition and Alzheimer's disease: The detrimental role of a high carbohydrate
diet. Eur J Intern Med, 22(2),
- Snitz, B. E., O'Meara, E. S., Carlson, M. C., Arnold, A. M.,
Ives, D. G., Rapp, S. R., et al. (2009). Ginkgo biloba for preventing cognitive
decline in older adults: a randomized trial. JAMA, 302(24), 2663-2670.
- Solomon, P. R., Adams, F., Silver, A., Zimmer, J., &
DeVeaux, R. (2002). Ginkgo for memory enhancement: a randomized controlled
trial. JAMA, 288(7), 835-840.
- Traykov, L., Rigaud, A. S., Cesaro, P., & Boller, F.
(2007). [Neuropsychological impairment in the early Alzheimer's disease]. Encephale, 33(3 Pt 1), 310-316.
- Uc, E. Y., Rizzo, M., Anderson, S. W., Shi, Q., & Dawson,
J. D. (2004). Driver route-following and safety errors in early Alzheimer
disease. Neurology, 63(5), 832-837.
- Wegiel, J., Gong, C. X., & Hwang, Y. W. (2011). The role
of DYRK1A in neurodegenerative diseases. FEBS
J, 278(2), 236-245.
- Wilson, R. S., Mendes De Leon, C. F., Barnes, L. L.,
Schneider, J. A., Bienias, J. L., Evans, D. A., et al. (2002). Participation in
cognitively stimulating activities and risk of incident Alzheimer disease. JAMA, 287(6), 742-748.
- Yu, F. (2011). Guiding Research and Practice: A Conceptual
Model for Aerobic Exercise Training in Alzheimer's Disease. Am J Alzheimers Dis Other Demen.